As of September 2024, Beximco Pharmaceuticals has a market cap of $125.93M. This makes Beximco Pharmaceuticals the world's 19945th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $236.92M | -2.53% |
2023 | $243.07M | -23.15% |
2022 | $316.29M | -55.56% |
2021 | $711.65M | 21.50% |
2020 | $585.72M | 139.13% |
2019 | $244.94M | 2.22% |
2018 | $239.61M | -25.00% |
2017 | $319.48M | 7.14% |
2016 | $298.18M | 121.89% |
2015 | $134.39M | 51.22% |
2014 | $88.87M | 40.51% |
2013 | $63.25M | -22.67% |
2012 | $81.78M | - |